FDA oks 2nd booster shot for senior citizens, immunocompromised, and health frontliners

FDA, nagbigay na ng EUA para sa 4th dose ng bakuna para sa senior citizens, immunocompromised patients, at frontliners

WHO recommends booster shots for immunocompromised individuals and senior citizens who received Sinovac or Sinopharm vaccines

USA FDA, inaprubahan na ang pagbibigay ng booster shot sa mga immunocompromised na indibidwal

Rollout for booster shots of senior citizens, immunocompromised individuals begins

Ceremonial vaccination ng booster shots sa mga immunocompromised individuals at senior citizens, isinagawa sa EAMC

Guidelines para sa ikalawang booster shot sa senior citizens at immunocompromised, binubuo na

Booster shots para sa senior citizens at immunocompromised, sinimulan na ngayong araw

Senior citizens at immunocompromised individuals, pwede na ring turukan ng booster shots

Vaccine expert panel, inirerekomenda ang pagbibigay ng 2nd booster dose sa senior citizens at immunocompromised; Publiko, hinimok na magpabakuna sa ‘Bayanihan Bakunahan’ 4

Medical frontliners, maaaring pumili ng vaccine brand para sa booster shot ayon sa DOH; FDA, inanunsyo rin na may EUA na ang COVID-19 vaccine ng Covavax

Pagbabakuna ng booster shot ng COVID-19 vaccines, pinag-aaralan na ng DOH; Health workers at immunocompromised individuals, prayoridad na mabigyan ng booster shot vs. COVID-19

Rollout ng 2nd booster shot sa mga immunocompromised, umarangkada na sa Metro Manila; DOH, tiniyak na sapat ang bakuna para sa 2nd booster

Booster shots sa healthcare workers at immunocompromised sa 4th quarter ng 2021, inaprubahan ng DOH; Pfizer vaccine, inirekomenda na booster shot sa mga nakatanggap ng AstraZeneca, Sinovac, at Moderna vaccines

Nasa 1-K mga senior citizen at immunocompromised, target mabigyan ng booster shot sa San Juan City ngayong araw; Mga tuturukan, malayang makakapili ng brand para sa booster shot

DOH, isinusulong na mabigyan na ng 2nd booster dose ang mga seafarers at OFWs; Mga may comorbidity na hindi immunocompromised, dapat na ring mabigyan ng 2nd booster shot ayon sa Vaccine Expert Panel

32 bagong kaso ng BA.5 Omicron subvariant, naitala; Booster shot para sa mga immunocompromised na edad 12-17, umarangkada na

Rollout ng 2nd booster para sa immunocompromised individuals, nagsimula na

Pagbabakuna ng booster shot sa edad 12-17 na hindi immunocompromised, hiniling ni Sec. Concepcion

Pagbabakuna ng 2nd COVID-19 booster shot para sa mga immunocompromised, umarangkada sa NCR

Rollout ng 2nd booster sa bansa, simula na sa Lunes para sa mga immunocompromised

Australian adults now eligible for a fifth booster shot

Covid-19 booster shots: Media practitioners to receive it and lead by example

MMDA personnel get booster shots

Updated COVID boosters for the fall

New COVID booster shots go out this week

Dr. Solante: Vulnerable sector, individuals who have not received booster shot should be first to be inoculated with bivalent vaccine

PBBM visits Albay to lead distribution of aid to #ElNiñoPH affected farmers, fisherfolk

MMDA conducts clearing operations in Q.C.

New board of directors acting member Imelda Papin lays out plans for PCSO

PDIC urges more Filipinos to open up savings account

Tom Brady roast dominates with 1.7B minutes of views

Disney’s ‘The Acolyte’ reaches 4.8M views

Tense moments as family onboard banca tries to escape wave of mud and soil in Abuyog, Leyte

Drone video shows state of landslide-hit barangay in Baybay, Leyte

Thousands flock to NAIA for Holy Week exodus

Long queues of vehicles seen in NLEX this Holy Wednesday

Long queues seen in PITX ticket booths for Bicol-bound trips

Passengers flock to Batangas port this Holy Wednesday

FDA Reverses Ban on Juul E-Cigarettes

FDA Advisers Recommend Omicron-Focused COVID Boosters for Fall

FDA Reviewing Data on MDMA for Potential Approval of Groundbreaking PTSD Treatment

AWANI Tonight: Synthetic nicotine in vapes may be more potent than nicotine, FDA finds

Why food recalls are on the rise in the US

Moderna's RSV Vaccine Approval Faces Setback as FDA Delays Decision